Cancer Clinical Trials

A listing of Cancer medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 1000 clinical trials
Featured trial
  • 380 views
  • 11 Aug, 2022
  • 150 locations
Featured trial
Study of Oral Navitoclax Tablet in Combination With Oral Ruxolitinib Tablet to Assess Change in Spleen Volume in Adult Participants With Relapsed/Refractory Myelofibrosis

www.MyelofibrosisResearch.com Myelofibrosis (MF) is a bone marrow illness that affects blood-forming tissues in the body. MF disturbs the body's normal production of blood cells, causing extensive scarring in the bone marrow. This leads to severe anemia, weakness, fatigue, and an enlarged spleen. The purpose of this study is to assess …

  • 835 views
  • 10 Aug, 2022
  • 226 locations
Featured trial
  • 0 views
  • 11 Aug, 2022
  • 120 locations
Featured trial
A Study Evaluating Safety, PK, and Efficacy of Tafasitamab and Parsaclisib in Participants With Relapsed/Refractory Non Hodgkin Lymphoma (R/R NHL) or Chronic Lymphocytic Leukemia (CLL) (topMIND)

) and dosing regimen that was established for each of the 2 compounds as a treatment option for adult participants with R/R B-cell malignancies.

lymphoma
anti-cd20 antibody
btk inhibitor
leukemia
cyclin d1
  • 2 views
  • 09 Aug, 2022
  • 40 locations
Featured trial
INCB000928 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Anemia Due to Myeloproliferative Disorders

This Phase 1/2, open-label, dose-finding study is intended to evaluate the safety and tolerability, PK, PD, and efficacy of INCB000928 administered as monotherapy or in combination with ruxolitinib in participants with MF who are transfusion-dependent or presenting with symptomatic anemia. This study will consist of 2 parts: dose escalation and …

anemia
  • 12 views
  • 10 Aug, 2022
  • 19 locations
Featured trial
Study to Evaluate the Efficacy and Safety of Pemigatinib in Participants With Previously Treated Glioblastoma or Other Primary Central Nervous System Tumors Harboring Activating FGFR1-3 Alterations (FIGHT-209)

This is an open-label, monotherapy study of pemigatinib in participants with recurrent glioblatoma (GBM) or other primary CNS tumors with an activating FGFR1-3 mutation or fusion/rearrangement

karnofsky performance status
measurable disease
EGFR
oligodendroglioma
TERT
  • 3 views
  • 10 Aug, 2022
  • 7 locations
Featured trial
To Assess the Safety and Tolerability of INCB000928 in Participants With Myelodysplastic Syndromes or Multiple Myeloma.

This Phase 1/2, open-label, dose-finding study is intended to evaluate the safety and tolerability, PK, PD, and efficacy of INCB000928 administered as monotherapy in participants with MDS or MM who are transfusion-dependent or present with symptomatic anemia.

carfilzomib
myelodysplastic syndromes
lenalidomide
bortezomib
chronic myelomonocytic leukaemia
  • 0 views
  • 09 Aug, 2022
  • 13 locations
Featured trial
Phase 3 Study of MRTX849 vs Docetaxel in Patients With Advanced Non-Small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-12)

This Phase 3 study will evaluate the efficacy of the investigational agent MRTX849 versus docetaxel in patients who have been previously treated for metastatic NSCLC with a KRAS G12C mutation.

recurrent non-small cell lung cancer
advanced lung cancer
metastatic non-small cell lung cancer
lung metastases
refractory non-small cell lung cancer
  • 34 views
  • 12 Aug, 2022
  • 164 locations
Featured trial
Phase 2 Trial of MRTX849 in Combination with Pembrolizumab in Patients with Advanced Non-Small Cell Lung Cancer with KRAS G12C Mutation (KRYSTAL-7)

This Phase 2 study evaluates the clinical activity and safety of MRTX849 in combination with pembrolizumab in cohorts of patients with advanced NSCLC with KRAS G12C mutation and any PD-L1 TPS.

pembrolizumab
KRAS
  • 36 views
  • 10 Aug, 2022
  • 83 locations
Featured trial
Diabetes - Escondido CA

Be part of a new approach to diabetes care! AMCR Institute is currently recruiting for clinical trials to evaluate medical devices and investigational medications for pediatric and adult individuals with Type 1, Type 2 Diabetes and obesity. AMCR Institute's team is committed to providing superior service to our volunteers and …

  • 304 views
  • 12 Aug, 2022
  • 1 location